Staphylococcus aureus bacteremia in an Indian tertiary care hospital: Observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene

International Journal of Infectious Diseases

Volumn 17, Issue 11, 2013, Pages e1051-e1055

  Eshwara, Vandana Kalwaje ^a   Munim, Frenil ^a   Tellapragada, Chaitanya ^a   Kamath, Asha ^a   Varma, Muralidhar ^a   Lewis, Leslie Edward ^a   Mukhopadhyay, Chiranjay ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Bacteremia; MRSA; PVL gene; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GLYCOPEPTIDE; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; COHORT ANALYSIS; COMMUNICABLE DISEASE; FATALITY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INDIAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL SKIN INFECTION; TERTIARY HEALTH CARE;

BACTEREMIA; MRSA; PVL GENE; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, NEOPLASM; EXOTOXINS; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; LEUKOCIDINS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885377256     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.06.002     Document Type: Article

References (36)

1. Naber C.K. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009, 48:S231-S237.
2. Fowler V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
3. Collignon P., Nimmo G.R., Gottlieb T., Gosbell I.B. Australian Group on Antimicrobial Resistance. Staphylococcus aureus bacteremia. Australia. Emerg Infect Dis 2005, 11:554-561.
4. Nickerson E.K., Hongsuwan M., Limmathurotsakul D., Wuthiekanun V., Shah K.R., Srisomang P., et al. Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 2009, 4:e4308.
5. Laupland K.B., Ross T., Gregson D.B. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008, 198:336-343.
6. Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., Winn Washington C. Colour atlas and text book of diagnostic microbiology 2006, Lippincott, Philadelphia. 6th ed.
7. Performance standards for antimicrobial disk susceptibility tests; approved standard M2-A10 2009, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA. 10th ed.
8. McClure J.A., Conly J.M., Lau V., Elsayed S., Louie T., Hutchins W., et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol 2006, 44:1141-1144.
9. Seetha K.S., Bairy I., Shivananda P.G. Bacteraemia in high-risk patients. Indian J Med Sci 2002, 56:391-396.
10. Mathur P., Kapil A., Das B., Dhawan B. Epidemiology and microbiology of nosocomial bacteraemia at an Indian tertiary care hospital. Trop Doct 2005, 35:53-54.
11. Mehta M., Dutta P., Gupta V. Antimicrobial susceptibility pattern of blood isolates from a teaching hospital in north India. Jpn J Infect Dis 2005, 58:174-176.
12. Sader H.S., Jones R.N., Andrade-Baiocchi S., Biedenbach D.J. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 2002, 44:273-280. SENTRY Participants Group (Latin America).
13. Karlowsky J.A., Jones M.E., Draghi D.C., Thornsberry C., Sahm D.F., Volturo G.A. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004, 3:7.
14. European Antimicrobial Resistance Surveillance System annual report 2006 2007, EARSS Management Team, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
15. Pasumbal E., Peña A. Epidemiology and outcome of bacteremia at St Luke's Medical Center: a one-year prospective study. Phil J Microbiol Infect Dis 2004, 33:53-67.
16. Karunakaran R., Raja N.S., Ng K.P., Navaratnam P. Etiology of blood culture isolates among patients in a multidisciplinary teaching hospital in Kuala Lumpur. J Microbiol Immunol Infect 2007, 40:432-437.
17. Phetsouvanh R., Phongmany S., Soukaloun D., Rasachak B., Soukhaseum V., Soukhaseum S., et al. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 2006, 75:978-985.
18. Styers D., Sheehan D.J., Hogan P., Sahm D.F. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006, 5:2.
19. Chalfine A., Kitzis M.D., Bezie Y., Benali A., Perniceni L., Nguyen J.C., et al. Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship. Antimicrob Resist Infect Control 2012, 1:1-18.
20. Reynolds R. Antimicrobial resistance in the UK and Ireland. J Antimicrob Chemother 2009, 64(Suppl 1):i19-i23.
21. Sood M., Sharma S., Grover N. Staphylococcus aureus infection: clinical profile and outcome among children admitted to a tertiary care hospital in developing economy. Pediatric Infectious Disease 2012, 4:101-106.
22. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771. Active Bacterial Core Surveillance (ABCs) MRSA Investigators.
23. Fowler V.G., Li J., Corey G.R., Boley J., Marr K.A., Gopal A.K., et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997, 30:1072-1078.
24. Hill P.C., Birch M., Chambers S., Drinkovic D., Ellis-Pegler R.B., Everts R., et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31:97-103.
25. Fowler V.G., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163:2066-2072.
26. Wang J.L., Chen S.Y., Wang J.T., Wu G.H., Chiang W.C., Hsueh P.R., et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008, 46:799-806.
27. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
28. Francis J.S., Doherty M.C., Lopatin U., Johnston C.P., Sinha G., Ross T., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005, 40:100-107.
29. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
30. Gonzalez B.E., Martinez-Aguilar G., Hulten K.G., Hammerman W.A., Coss-Bu J., Avalos-Mishaan A., et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005, 115:642-648.
31. Klein J.L., Petrovic Z., Treacher D., Edgeworth J. Severe community-acquired pneumonia caused by Panton-Valentine leukocidin-positive Staphylococcus aureus: first reported case in the United Kingdom. Intensive Care Med 2003, 29:1399.
32. Prevost G., Couppie P., Prevost P., Gayet S., Petiau P., Cribier B., et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995, 42:237-245.
33. von Eiff C., Friedrich A.W., Peters G., Becker K. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 2004, 49:157-162.
34. Melles D.C., van Leeuwen W.B., Boelens H.A., Peeters J.K., Verbrugh H.A., van Belkum A. Panton-Valentine leukocidin genes in Staphylococcus aureus. Emerg Infect Dis 2006, 12:1174-1175.
35. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
36. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005, 43:2384-2390.